The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
Clinical trial NCT05778253 · RECRUITING
Trial details
- NCT number
- NCT05778253
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-23
- Primary completion
- 2028-09-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.